Myelodysplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Expanded Access Program for Magrolimab
Conditions:   Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome;   Relapsed/Refractory Acute Myeloid Leukemia Intervention:   Biological: Magrolimab Sponsor:   Gilead Sciences Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2022 Category: Research Source Type: clinical trials

Phase II Trial of CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
Conditions:   Myelodysplastic Syndromes;   Graft Vs Host Disease;   Graft-versus-host-disease Interventions:   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine;   Device: CliniMACS CD34+ enriched, T-cell depleted peripheral blood stem cell (PBSC) Sponsor:   Baptist Health South Florida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2022 Category: Research Source Type: clinical trials